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Ubinuclein-1 confers histone H3.3-specific-binding
by the HIRA histone chaperone complex
M. Daniel Ricketts1,2, Brian Frederick3, Henry Hoff3, Yong Tang3, David C. Schultz3, Taranjit Singh Rai4,5,
Maria Grazia Vizioli4, Peter D. Adams4 & Ronen Marmorstein1,2,6
Histone chaperones bind specific histones to mediate their storage, eviction or deposition
from/or into chromatin. The HIRA histone chaperone complex, composed of HIRA,
ubinuclein-1 (UBN1) and CABIN1, cooperates with the histone chaperone ASF1a to mediate
H3.3-specific binding and chromatin deposition. Here we demonstrate that the conserved
UBN1 Hpc2-related domain (HRD) is a novel H3.3-specific-binding domain. Biochemical and
biophysical studies show the UBN1-HRD preferentially binds H3.3/H4 over H3.1/H4. X-ray
crystallographic and mutational studies reveal that conserved residues within the UBN1-HRD
and H3.3 G90 as key determinants of UBN1–H3.3-binding specificity. Comparison of the
structure with the unrelated H3.3-specific chaperone DAXX reveals nearly identical points of
contact between the chaperone and histone in the proximity of H3.3 G90, although the
mechanism for H3.3 G90 recognition appears to be distinct. This study points to UBN1 as the
determinant of H3.3-specific binding and deposition by the HIRA complex.
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I
n metazoan cells, there are two major H3 variants: H3.1 is
deposited by the trimeric CAF-1 complex during DNA
replication1 and repair of ultraviolet-induced DNA damage2,
while histone H3.3 is deposited in a replication-independent
manner1,3 by either DAXX/ATRX largely at heterochromatin,
including pericentromeres, telomeres and endogenous retroviral
elements4–7, or by the HIRA complex predominantly at gene
regulatory regions, gene bodies, developmentally regulated
genes4,8–13, and sites of DNA and chromatin damage and
repair11,14–16. However, DAXX/ATRX and HIRA likely also have
some overlapping functions. For example, DAXX promotes H3.3
deposition at gene regulatory regions of activated neurons and
both HIRA and DAXX are involved in H3.3 deposition in
non-proliferating senescent cells17. While the H3/H4 histone
chaperone ASF1a interacts with both CAF-1 and HIRA
complexes and binds to both H3.3/H4 and H3.1/H4 for histone
deposition1,18–20, CABIN1 and ubinuclein-1 (UBN1) are unique
members of the HIRA complex1. CABIN1 and UBN1 were
initially identified as a negative regulator for calcineurin signalling
in T lymphocytes21 and as a ubiquitously expressed nuclear
protein that interacts with cellular and viral transcription
factors22, respectively, and later shown to be functional
members of the HIRA histone chaperone complex1,8,12,23.
The human HIRA complex is orthologous to the Sacchar-
omyces cerevisiae Hir histone chaperone complex, which regulates
histone gene transcription24,25 and mediates replication-
independent deposition of H3/H4 in yeast26. HIRA is
homologous to Hir1 and Hir2 (ref. 27), CABIN1 is homologous
to Hir3 (refs. 1,23,28) and UBN1 is homologous to Hpc2 with
strong sequence conservation in the Hpc2-related domain
(HRD)8,28. Although the UBN1-HRD was initially proposed to
mediate association with the WD repeats of HIRA8, we more
recently demonstrated that a less conserved region of UBN1 that
resides sixty residues N terminal to the HRD is, in fact,
responsible for HIRA-binding activity in UBN1; we named this
domain the NHRD29 (Fig. 1a). These data in combination with
the observations of others28 led us to the hypothesis that that the
highly conserved UBN1-HRD may function to confer histone
H3.3-binding specificity.
The molecular basis for how the HIRA complex selectively
binds to H3.3, which differs from H3.1 by only 5 amino acids, is
unknown. In this study, we report that H3.3-specific binding by
the HIRA complex is mediated by the UBN1-HRD. We
demonstrate that the UBN1-HRD specifically binds to H3.3/H4
over H3.1/H4 in a manner that is independent of the protein
HIRA. Determination of a crystal structure containing a
UBN1-HRD peptide bound to H3.3/H4/Asf1 and mutational
studies aided us in identification of residues within the UBN1-
HRD and H3.3 that contribute to the specificity and strength of
the UBN1/H3.3 interaction. In addition, the UBN1/H3.3/H4/Asf1
crystal structure reveals striking structural similarity between
UBN1/H3.3/H4 and DAXX/H3.3/H4. Together, our results
demonstrate that the UBN1-HRD mediates H3.3-specific binding
by the HIRA complex and exemplify the evolutionary power of
the H3.3 surface in encouraging the disparate histone chaperones
UBN1 and DAXX to adopt similar structures.
Results
A region of UBN1 containing the HRD specifically binds to H3.3.
We initially compared H3.3/H4- and H3.1/H4-binding activity
of the HIRA(1–405)/GST-UBN1(41–175) complex with that
of GST-UBN1(92–175) (Fig. 1b). HIRA(1–405) has predicted
WD repeats and is the minimum UBN1-binding domain,
UBN(41–175) has both the NHRD and HRD while UBN1
(92–175) harbours only the HRD. GST-tagged proteins were
incubated with H3.1/H4 or H3.3/H4 alone or in competition with
the reciprocal His-H3/His-H4 (H3.1 or H3.3) complex and sub-
jected to GST pull-down. We observed H3.3/H4 selective binding
over H3.1/H4 for both HIRA(1–405)/GST-UBN1(41–175) and
GST-UBN (92–175), indicating that a UBN1-HRD containing
protein region can specifically bind H3.3 without contribution
from HIRA (Fig. 1b). In a control pull-down study, we demon-
strated that GST-ASF1a binds to H3.1/H4 and H3.3/H4 with
equal affinity, while GST-UBN1(92–175) specifically binds to
H3.3/H4 (Supplementary Fig. 1). Specificity for H3.3/H4 over
H3.1/H4 was especially marked when UBN1 was presented with
both H3/H4 variant complexes simultaneously. Specificity for
H3.3 was apparent in this assay regardless of whether H3.3 was
His-tagged or untagged. Interaction of UBN1(92–175) with
H3.3/H4 and H3.1/H4 was monitored directly with isothermal
titration calorimetry (ITC) and indirectly through competition
binding against a fluorescein isothiocyanate (FITC)-labelled
UBN1 peptide (Fig. 1c; Fig. 2d; Supplementary Fig. 3a). Both
assays demonstrated that UBN1(92–175) binds to H3.3/H4 with a
dissociation constant in the low micromolar range (B7–17 mM
depending on the assay used), while significant interaction with
H3.1/H4 could not be detected with either assay (Figs 1c and 2d).
Conserved HRD residues are required for binding to H3.3/H4.
UBN1 residues involved in the interaction with H3.3/H4 were
investigated with an alanine scanning mutagenesis experiment
targeted at the UBN1-HRD. A survey of the HRD was conducted
by testing 18 GST-UBN1(92–175) triple alanine mutants in the
context of GST-UBN1(92–175), spanning residues 122–175, for
their ability to pull down with H3.3/H4. The strongest ablation of
binding was observed for mutants of UBN1 residues 135–142
(Supplementary Fig. 2a,b), containing some of the most highly
conserved residues of the HRD (Figs 1a and 2a). We then focused
on this region by generating 27 alanine point mutations spanning
UBN1 residues 122–148 (Fig. 2a). UBN1 point mutants were
tested for interaction with H3.3/H4 using GST pull-down assays
and fluorescence polarization histone-binding assays. Both
experiments showed that the UBN1 Y132A, D133A, D136A,
F138A, I139A, D140A and N141A mutants exhibited reduced
histone binding relative to wild-type (WT) UBN1 (Fig. 2b–d;
Supplementary Fig. 3). All of these residues are strictly conserved
from yeast to human (Fig. 2a), with the exception of N141 (which
is sometimes conservatively substitute to a D). Alanine mutants of
UBN1 residues 122–148 were additionally subjected to pull down
with H3.1/H4, and these mutants showed either no effect or a
significantly smaller effect on UBN1 association with H3.1/H4,
suggesting that the most conserved residues within the
UBN1-HRD play a predominant role in H3.3-binding specificity
(Supplementary Fig. 4).
A minimal UBN1-HRD fragment, consisting of residues
122–148, was then investigated to determine whether this
conserved core region is sufficient for H3.3-binding specificity.
In a pull-down assay GST-UBN1(122–148) exhibited specificity
for binding to H3.3/H4 in comparison with H3.1/H4 (Fig. 3b).
ITC and FP histone-binding assays were employed to quantita-
tively confirm the H3.3 specificity of the UBN1(122–148) peptide
(Fig. 3c; Supplementary Fig. 5b). While UBN1(122–148) main-
tains binding specificity for H3.3/H4 in comparison with
H3.1/H4, UBN1(92–175) binds to H3.3/H4 about three- to
sixfold more strongly than UBN1(122–148). This suggests that
residues flanking 122–148 of the UBN1-HRD also contribute to
H3.3-binding affinity. UBN1(92–148) and UBN1(122–175) were
analysed for binding to H3.3/H4 and H3.1/H4 with ITC
to address the contributions of these flanking residues. We found
that both UBN1 fragments bind H3.3/H4 with similar
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dissociation constants (Kd¼B14–16 mM) while binding with
H3.1/H4 was undetectable (Supplementary Fig. 5c). This binding
capacity is stronger than UBN1(122–148) but weaker than
UBN1(92–175), further suggesting that UBN1 residues 92–121
and 149–175 contribute to the binding affinity of H3.3/H4.
H3.3 residue G90 mediates UBN1 specificity. To establish the
amino acids in H3.3 and H3.1 that confer specific binding of the
former to UBN1-HRD, we analysed the five residues that differ
between H3.3 and H3.1 with a residue-swap mutagenesis
experiment. The five differing residues are clustered in three
patches along the sequence of H3 (S31A, SAVM87-90AAIG and
C96S) (Fig. 3a; Supplementary Fig. 6a). We first tested
H3.3(S31A), H3.3(SAVM) and H3.3(S96C) for binding to
GST-UBN1(92–175) in pull-down assays, in competition with
WT His-H3.1/His-H4 (Supplementary Fig. 6b). Only the
H3.3(SAVM) mutant abolished H3.3-specific binding from
UBN1 (Supplementary Fig. 6b). To assess the individual residue
effects from this patch, H3.3 A87S, I89V and G90M mutants were
applied in the same pull-down assays; only H3.3(G90M)
prevented binding to UBN1 (Supplementary Fig. 6c). The reverse
experiment, with H3.3 residues introduced into H3.1, showed
that the H3.1(M90G) mutant uniquely acquired binding to UBN1
(Supplementary Fig. 6d). GST-ASF1a FL and GST-UBN1
(92–175) were compared for selectivity between H3.3(SAVM)
and H3.1(AAIG) mutants, and only GST-UBN1(92–175)
exhibited binding specificity for H3.1(AAIG) (Supplementary
Fig. 6e). GST-UBN1(122–148) was analysed for selectivity
between the crucial histone residue-swap mutants and showed
decreased binding to H3.3(SAVM) and H3.3(G90M), but
increased binding to H3.1(AAIG) and H3.1(M90G) (Fig. 3b).
A more quantitative analysis of the effect of H3.1 and H3.3
mutants on UBN1(122–148) binding was performed with ITC
and demonstrated that the H3.3(G90M) and H3.3(SAVM)
mutants had about a threefold decrease in UBN1(122–148)
binding relative to H3.3 WT, and that the H3.1(M90G) and
H3.1(AAIG) swap mutants bound UBN1(122–148) nearly as well
as H3.3 WT (Fig. 3c).
UBN1/H3.3/H4/Asf1 structure reveals mode of H3.3 binding.
Having determined that the UBN1-HRD is necessary and suffi-
cient for selective binding of H3.3 over H3.1 to better understand
this at the molecular level, we set out to determine a crystal
structure of the UBN1/H3.3 interaction. We were unable to
obtain crystals of UBN1 in complex with H3.3/H4 alone.
Previously, a structure of the Asf1 core domain bound to
H3.1/H4-lacking N-terminal tails was determined. We obtained
this construct and modified it to generate a Asf1/H3.3/H4
complex that we successfully used for cocrystallization with a
UBN1 peptide harbouring the HRD region. From those crystals,
we determined the 2.3 Å X-ray crystal structure of a complex
containing human UBN1(122–142) bound to Xenopus laevis
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Figure 1 | A region of UBN1 containing the Hpc2-related domain (HRD) is able to specifically bind to histone H3.3. (a) Sequence alignment comparing
two highly conserved domains in Homo sapiens UBN1, Drosophila melanogaster Yemanuclein and Saccharomyces cerevisiae Hpc2. (b) GST pull-down histone-
binding assay. Binding to H3.3/H4 and H3.1/H4 is tested separately in a single input H3/H4 pull-down (left), and in competition by subjecting an
equimolar mixture of H3/H4 and His-H3/His-H4 to pull down (right). The H3.3-specific binding activity of GST-UBN1(41–175)/HIRA(1–405) (top),
GST-UBN1(92–175) (middle) and free GST (bottom) is compared. (c) Isothermal titration calorimetry was used to quantitatively compare UBN1(92–175)
binding with H3.3/H4 (left) and H3.1/H4 (right), ± values represent the standard error of the ITC fit using Origin 7.0. ND, not determined.
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H3.3(60–133), X. laevis H4(21–102) and S. cerevisiae Asf1(1–154)
(Fig. 4a; Supplementary Table 1). Not surprisingly, the
Asf1/H3.3/H4 component of the structure superimposes perfectly
with the previously reported Asf1/H3.1/H4 structure (root mean
squared deviation¼ 0.821Å for all identical atoms) since the
differences between H3.3 and H3.1 do not reside at the
Asf1–histone interface. An omit map confirms electron density
for UBN1 residues 122–142 (Supplementary Fig. 7). UBN1
residues 122–127 form a short helix and residues 128–142 a coil,
with the coil wrapping over a surface of H3.3 formed by helices 1
and 2 and the intervening turn. The UBN1 helix (residues
122–127) projects away into solvent (Fig. 4b). Confirming the
biochemical studies, the UBN1-HRD makes intimate interactions
with H3.3 centred around G90 (Fig. 4a,b). The UBN1–H3.3
interface is nucleated by UBN1 residues F138 and Y132 that
protrude into largely hydrophobic pockets on H3.3 and position
the coil of residues 128–132 in a saddle that sits over the top of
H3.3 G90 (Fig. 4b). The hydroxyl group of UBN1 Y132 forms a
hydrogen bond with the side chain of H3.3 Q93 (Fig. 4c). The
aromatic ring of UBN1 Y132 makes extensive van der Waals
interactions with the aliphatic side chain of H3.3 K64; a hydrogen
bond with the UBN1 Y130 backbone carbonyl locks H3.3 K64
into place above UBN1 Y132 (Fig. 4c). A van der Waals inter-
action between the beta carbon of UBN1 D133 and the side chain
of H3.3 L65 may also help anchor UBN1 Y132 into position
(Fig. 4c). UBN1 F138 sits in a hydrophobic pocket where it forms
an extensive network of van der Waals interactions with the
aliphatic chain of H3.3 R72 and the aromatic ring of H3.3 F84, as
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Figure 2 | Conserved residues in the UBN1-HRD are required for binding with H3.3/H4. (a) Sequence alignment comparing HRD residues in Homo
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well as supporting interactions with H3.3 V71, A77 and I89
(Fig. 4c). UBN1 I139 makes van der Waals interactions with the
H3.3 I89 side chain and helps to cap the hydrophobic pocket in
which UBN1 F138 binds (Fig. 4c). UBN1 D136 and D140 form
hydrogen bonds with H3.3 R72 and H4 T80, respectively, while
the UBN1 N141 side chain makes hydrogen-bonding interactions
with both the backbone amide and the side chain hydroxyl of
H3.3 S86 (Fig. 4c). The backbone carbonyl from UBN1 F138 and
backbone amide from UBN1 D140 form hydrogen bonds with
the backbone amide and carbonyl from H3.3 F84 to further
solidify the UBN1/H3.3 interaction (Fig. 4c). Notably, the
structure reveals that evolutionarily conserved UBN1 residues
whose mutation disrupts H3.3 binding form hydrogen bond or
van der Waals interaction with H3.3/H4 (Fig. 4c). UBN1 residues
that are not sensitive to mutation (E134, S135 and S137) do not
make contact with H3.3/H4 (Supplementary Fig. 8).
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Figure 3 | H3.3 residue G90 mediates UBN1 specificity. (a) Sequence alignment comparing human histones H3.1 and H3.3 with the five amino-acid
differences highlighted in grey (b) GSTpull-down assay comparing the ability of UBN1(122–148) to select between histone mutants where critical residues
have been swapped between H3.1 and H3.3. UBN1 binding with wild-type H3.3/H4 and H3.1/H4 was analysed in addition to H3/H4 carrying several
H3 mutants: H3.3(G90M), H3.1(M90G), H3.3(SAVM) and H3.1(AAIG). (c) Isothermal titration calorimetry quantification of the UBN1(122–148)
interaction with wild-type and mutant H3/H4 complexes. Dissociation constant (Kd) and stoichiometry of UBN1 binding to H3/H4 are reported,
±values represent the standard error of the ITC fit using Origin 7.0. ND, not determined.
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Asf1 and histones tails do not alter UBN1/H3.3 interaction.
To confirm the veracity of the interactions between UBN1 and
H3.3/H4 observed in our crystal structure, we investigated
how the presence of Asf1 in complex with H3/H4 affects the
interaction between UBN1 and H3/H4. We conducted ITC
to determine the affinity of UBN1(122–148) for complexes
assembled with Asf1 and FL H3/H4 or H3(60–135)/H4(20–102)
lacking the N-terminal tails (Supplementary Fig. 9). We found
that UBN1(122–148) interacts with the Asf1/H3.3(FL)/H4(FL)
complex with a dissociation constant (B49 mM) comparable to
that of UBN1(122–148) binding to H3.3/H4 alone (B40–46 mM
depending on the assay); no significant interaction between
UBN1(122–148) and Asf1/H3.1(FL)/H4(FL) was detected
(Supplementary Fig. 9a). We then tested UBN1 (122–148)
binding with Asf1/H3.3(60–135)/H4(20–102). The dissociation
constant determined for this interaction (B110mM) is roughly
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Figure 4 | Crystal structure of the UBN1/H3.3/H4/Asf1 complex at 2.3-Å resolution. (a) Overall architecture of the UBN1/H3.3/H4/Asf1 complex
with the position of H3.3 G90 highlighted in yellow. The structure is composed of UBN1 122–148, H3.3 60–133, H4 21–102 and Asf1 1–154. (b) UBN1 has
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labelled. (c–d) Detailed stereo view of UBN1 and DAXX interactions with H3.3/H4 showing conserved interaction surfaces. (e) Alignment of the
UBN1/H3.3/H4/Asf1 and DAXX/H3.3/H4 structures illustrating structural similarity between UBN1 and DAXX. (f) Surface representation of UBN1 shows
that residues 128–132 rest closely over H3.3 G90 (top) and would likely sterically occlude binding with H3.1 M90 (bottom). M90 is represented by
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twofold weaker than for UBN1(122–148) binding to the
Asf1/H3.3(FL)/H4(FL) complex, although specificity for H3.3/H4
over H3.1/H4 was still evident (Supplementary Fig. 9b). These
data suggest that the presence of Asf1 in complex with the
histones does not significantly influence the binding and
specificity of the UBN1-HRD for H3.3/H4 over H3.1/H4.
UBN1 and DAXX bind to H3.3/H4 with structural similarity.
A comparison of the structure reported here with the
DAXX/H3.3/H4 complex30 reveals that while the histone
chaperones UBN1 and DAXX share no sequence conservation,
they bind the region of H3.3/H4 surrounding G90 with striking
similarity (Fig. 4c–e; Supplementary Table 2). The structural
similarity between how UBN1 and DAXX bind H3.3/H4 is
evident although the two chaperones have opposite orientations
of N- to C-terminal sequence when bound to H3.3/H4 and no
conservation when aligned in either orientation (Fig. 4e). DAXX
residues Y222, L210 and E209 are in essentially the same
positions and mediate the same interactions as UBN1 residues
Y132, I139 and D140, respectively (Fig. 4c,d; Supplementary
Fig. 10). In addition, L212 and L215 from DAXX maintain the
same van der Waals interaction network that UBN1 F138 forms
with H3.3 (Fig. 4c,d). Similar backbone interactions are also
maintained between the DAXX and UBN1 chaperones with H3.3
(Fig. 4c,d). Supplementary Table 2 summarizes the contacts that
UBN1 and DAXX make with key H3.3/H4 residues.
While DAXX and UBN1 contact H3.3/H4 in much the same
way, they do not use the same mechanism to select for H3.3 over
H3.1. UBN1 residues M128-Y132 sit in close proximity above
H3.3 G90 (Fig. 4b,f). A modelling of H3.3 G90M bound to UBN1
predicts that UBN1 would directly clash with a methionine at this
position, suggesting that UBN1 employs a mechanism of steric
occlusion to prevent unfavourable binding with H3.1 (Fig. 4f). In
contrast, the corresponding region within the DAXX/H3.3/H4
complex is solvent accessible and filled with a network of water
molecules that are proposed to provide steric bulk to occlude
binding with H3.1 (ref. 24; Fig. 5g). Although G90 is the primary
H3.3 residue responsible for UBN1 specificity, other H3.3-specific
residues may contribute to the UBN1 interaction. The delta
carbon from H3.3 I89 forms a van der Waals interaction with
UBN1 I139 and the H3.3 A87 beta carbon forms van der Waals
interactions with the beta and gamma carbons from UBN1 M128
(Fig. 5c). Both of these residues are unique to H3.3 and may be
responsible for the increased affinity that UBN1 has for the
SAVM(87–90)AAIG mutation in H3.1 in comparison with the
individual M90G mutation (Fig. 3c). Taken together, while UBN1
and DAXX bind to the same region of histone H3.3, they achieve
specificity for H3.3 over H3.1 by distinct mechanisms.
H3.3-specific binding occurs in HIRA/UBN1/CABIN1 complex.
To determine the contributions of the UBN1-HRD to H3.3
specificity in more complete HIRA and CABIN1-containing
complexes, we prepared complexes containing full-length HIRA,
UBN1 and CABIN1 proteins in WT form or bearing a UBN1
FID138-140AAA mutant, and assayed the ability of these
complexes to pull-down H3.3/H4 and H3.1/H4. This experiment
demonstrated that HIRA/UBN1 and HIRA/UBN1/CABIN1
complexes assembled from full-length proteins preferentially bind
to H3.3/H4 over H3.1/H4, and the preference is abolished in
complexes containing the UBN1 FID138-140AAA mutant (Fig. 5).
Discussion
Our data demonstrate that the UBN1-HRD is an evolutionarily
conserved H3.3-specific-binding domain that exploits residue
G90 in H3.3 to mediate specific binding and so deposition by the
HIRA histone chaperone complex. Many studies have shown that
HIRA complex specifically binds to and deposits H3.3 and is
required for deposition of H3.3 at selected genomic
regions1,4,7,9,11,17,31. Our structural analysis shows that this
specificity for H3.3 comes primarily from HIRA-bound UBN1,
not HIRA itself.
The specificity of the UBN1-HRD for G90 may be evolutio-
narily conserved with the Hpc2 subunit of the yeast Hir complex.
Recent data have shown that the yeast Hir complex can mediate
H3.3-specific deposition when ectopically expressed in human
cells and this specificity is dependent on the HRD in Hpc2
(ref. 32). In human cells, the UBN1-HRD functions to specifically
bind H3.3 over H3.1 and presumably other variants containing
M90 (H3.2, H3.4), and bulky L90 (CENP-A). H3.X, H3.Y and
H3.5 represent primate-specific H3 variants that also contain G90
(refs 33,34). Our data suggest that deposition of these H3 variants
could also be coordinated by UBN1 (HIRA complex) or
alternatively by DAXX.
We show that the structures of the UBN1 and DAXX
interactions with H3.3 have surprising similarity, although the
two chaperones use different mechanisms to mediate H3.3 G90
specificity. The structures are broadly similar in the sense that
both chaperones bind proximal to H3.3 G90 of H3.3/H4 with
nearly identical molecular contacts. However, unlike the UBN1-
HRD, DAXX wraps around the entire H3/H4 heterodimer to
make more extensive histone contacts that likely contribute to its
enhanced general H3/H4-binding affinity relative to UBN1-HRD.
Accordingly, it is possible that other UBN1 regions and/or other
proteins within the HIRA complex also contribute to general
histone-binding affinity35,36. In support of the participation of
additional UBN1 regions in H3/H4 binding is our observation
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that UBN1(92–175) binds H3.3/H4 about three- to sixfold more
strongly than UBN1(122–148) containing only the HRD
(Supplementary Fig. 5b,c).
With respect to G90 specificity, the steric bulk provided by
UBN1 residues 128–131 is perhaps more stringent than the water
molecules that DAXX positions over G90. These water molecules
can potentially be evacuated from the cavity to allow association
with histone H3 variants with a bulkier amino acid at residue 90.
This idea was demonstrated by a crystal structure of
DAXX/H3.3(G90M)/H4 (ref. 30), and supported by a recent
report37 that DAXX can mediate promiscuous deposition of the
H3 variant CENP-A that contains an L in the corresponding
position 90 of H3.
In addition, although we have demonstrated that UBN1 is
primarily responsible for H3.3-binding specificity of the HIRA
complex, the molecular basis for how the HIRA complex
mediates deposition requires further studies. Our UBN1/H3.3/
H4/Asf1 crystal structure may represent an intermediate
in a potential hand-off of histones between ASF1a/H3.3/H4
and HIRA/UBN1/CABIN1 complexes before deposition into
chromatin, as several studies suggest that deposition function
of the HIRA complex is not dependent on the presence of
ASF1a14,38,39. Nonetheless, the studies presented here provide
important new molecular insights into how the HIRA histone
chaperone complex specifically recognizes the histone H3.3
variant to regulate diverse genomic activities.
Methods
Multiple sequence alignments. Multiple sequence alignments for Figs 1a, 2a and
3a and Supplementary Figs 2a and 6a were generated using ClustalW2 (refs 40,41).
Alignments for Figs 1a and 2a and Supplementary Fig. 2a were further
formatted for publication using ESPript version 3.0 to better visualize sequence
conservation42. The alignment shown in Fig. 3a and Supplementary Fig. 6a was
manually formatted for publication.
Expression and purification of GST-tagged proteins. To generate the plasmid
DNA construct encoding GST-UBN1(41–175), the complementary DNA (cDNA)
encoding UBN1 residues 41–175 was PCR amplified from a previously described
UBN1 construct8 and ligated into the BamHI/XhoI sites of pFastBacGST
(Invitrogen). The plasmid DNA construct encoding HIRA(1–405) was generated
by PCR amplification and ligation of the cDNA endoding HIRA(1–405) into the
BamHI/XhoI sites of pFastBacHTB (Invitrogen), removal of the 6Histidine tag
was facilitated by mutagenesis using the Stratagene QuikChange protocol43.
GST-UBN1(41–175) and HIRA(1–405) were co-expressed in baculovirus-infected
Sf9 cells. GST-ASF1a FL, GST-UBN1(92–175) and GST-UBN1(122–148) were
generated through PCR by amplification of the proper cDNA sequence and ligation
into the BamHI/XhoI sites of a custom engineered pCDFduet-1 (Novagen)
Escherichia coli protein expression vector carrying an N-terminal GST tag that is
removable through TEV protease cleavage. GST-UBN1(92–175) mutants were
generated with the Stratagene QuikChange protocol43. GST-tagged proteins
produced in E. coli were induced with 0.8mM isopropyl-b-D-thiogalactoside
(IPTG) added to BL21-Gold(DE3) cells (Agilent) containing the desired expression
plasmid and cells were grown overnight at 18 C. To purify GST-tagged proteins
expressed in E. coli and Sf9, isolated cell pellets were suspended in 50ml lysis buffer
(PBS with 1mM PMSF and 5mM BME) per litre of cells and lysed with sonication.
Lysate was clarified by centrifugation and the supernatant was incubated with
glutathione agarose resin (Gold Biotechnology) for 1 h before washing the resin
with 60 column volumes of wash buffer (PBS with 5mM BME). GST-tagged
proteins were either eluted from the glutathione agarose with five column volumes
of elution buffer (PBS with 5mM BME and 20mM reduced glutathione) or
TEV protease was added to the protein-bound glutathione agarose and incubated
overnight to cleave the target protein off the GST fusion. Eluted GST-UBN1
(92–175), GST-UBN1(122–148), GST-ASF1a and GST-UBN1(41–175)/HIRA
(1–405) were then dialyzed overnight into buffer (20mM Tris pH 8.0, 25mM NaCl
and 5mM BME) for ion-exchange purification using a HiTrap Q HP column
(GE Healthcare). Protein released from GST by TEV cleavage was eluted with
six column volumes of buffer (HEPES pH 7.5, 750mM and 1mM TCEP) and
concentrated using a 3K cutoff centrifugal filter device (Millipore) before a final gel
filtration purification step with a Superdex S75 10/300 GL column (GE Healthcare).
Expression and purification of recombinant H3/H4. Human histones H3.3 and
H3.2 were amplified by PCR from a human cDNA library (ATCC 77430) and
ligated into the BamHI/XhoI sites of a custom engineered pETduet-1 (Novagen)
E. coli protein expression vector with an N-terminal 6Histidine tag that is
removable through TEV protease cleavage. A construct to express the amino-acid
sequence for H3.1 was generated by site-directed mutagenesis of H3.2. Human
histone H4 has a sequence that carries several rare codons, which are not conducive
to expression in E. coli, and to overcome this issue, we obtained a previously
described codon-optimized construct encoding H4 from X. laevis, which has the
same amino-acid sequence as human H4 (ref. 44). The codon-optimized X. laevis
H4 cDNA was PCR amplified and ligated into the BamHI/XhoI sites of the same
E. coli protein expression vector as the H3 constructs. H3 and H4 proteins were
expressed as inclusion bodies in BL21-Gold(DE3) cells (Agilent) induced with
0.8mM IPTG, protein was expressed for 4 h at 37 C. To purify H3 and H4, cells
were lysed with sonication in 50ml of lysis buffer (20mM Tris pH 7.5, 500mM
NaCl and 5mM BME) per litre of cells and lysate was clarified with centrifugation.
Cell pellets containing insoluble H3 or H4 were then resuspended in denaturing
buffer (20mM Tris pH 7.5, 500mM NaCl, 7.0M GdHCl and 5mM BME) and
clarified with centrifugation. Denatured H3 or H4 were incubated with Ni-NTA
agarose resin for 1 h before washing the resin with 60 column volumes of
denaturing buffer. Proteins were either eluted from the Ni-NTA agarose with five
column volumes of elution buffer (300mM imidazole, 20mM Tris pH 7.5, 500mM
NaCl, 7.0M GdHCl and 5mM BME). Eluted proteins were the dialyzed into water
and lyophilized. Refolding was conducted through resuspending the lyophilized H3
and H4 in denaturing buffer and mixing the two histones at 1:1 before refolding by
dialysis against two changes of non-denaturing buffer (20mM Tris pH 7.5, 1.0M
NaCl, 5mM BME and 1mM EDTA) followed by dialysis into a low-salt buffer
(20mM Tris pH 7.5, 100mM NaCl, 5mM BME and 1mM EDTA) before
ion-exchange purification using a HiTrap SP HP column (GE Healthcare). The
6Histidine tags on H3 and H4 were either left on the protein or removed by
treatment with TEV protease during the refolding reaction. Following ion exchange
the refolded H3/H4 complexes were further purified with gel filtration using a
Superdex 200 10/300 GL column (GE Healthcare). H3.3 and H3.1 residue-swap
point mutants were generated using the Stratagene QuikChange protocol43.
Synthetic peptides. Large scale peptide synthesis of UBN1(122–148) and
FITC-UBN1(127–148) was commissioned by a commercial vendor (Genscript).
GST pull-down histone-binding assay. GST-tagged UBN1 proteins and H3/H4
complexes were prepared as described above. The pull-down experiments
represented in Fig. 1 and Supplementary Fig. 2 were conducted by incubating 2 mM
GST-tagged protein with 2 mM H3/H4 (or 2 mM H3/H4 in competition with 2 mM
His-H3/His-H4) in a buffer containing 20mM HEPES pH 7.5, 500mM NaCl and
1mM TCEP at 4 C for 30min. Proteins were then subjected to pull down by
incubation with glutathione agarose resin (Gold Biotechnology) for 30min. Resin
was washed with 120 column volumes of buffer (20mM HEPES pH 7.5, 500mM
NaCl and 1mM TCEP) before elution of bound proteins by boiling resin in SDS
gel-loading buffer. The pull-down experiments represented in Figs 2 and 3 as
well as Supplementary Figs 1, 4, 5 and 6 were conducted by incubating 2 mM
GST-tagged protein with 4 mM H3/H4 (or 4 mM H3/H4 in competition with 4 mM
His-H3/His-H4) in a buffer containing 20mM HEPES pH 7.5, 750mM NaCl and
1mM TCEP at 4 C for 30min. Proteins were then subjected to pull down by
incubation with glutathione agarose resin (Gold Biotechnology) for 30min. Resin
was washed with 120 column volumes of buffer (20mM HEPES pH 7.5, 750mM
NaCl and 1mM TCEP) before elution of bound proteins by boiling resin in
SDS gel-loading buffer. Results of the pull-down assays were analysed though
visualization of input and pull-down samples with SDS–polyacrylamide gel
electrophoresis. Gels were stained using Coomassie Brilliant Blue G-250.
Isothermal titration calorimetry. Quantitative analysis of the UBN1/histone
interaction was conducted with a VP-ITC microcalorimeter (MicroCal). All
proteins/peptides were prepared in a buffer with 20mM HEPES pH 7.5, 750mM
NaCl and 1mM TCEP before ITC analysis. Experiments for Figs 1c and 3c were
conducted by injecting 0.450mM UBN1 into a calorimetry cell containing 30 mM
H3/H4, where UBN1 was injected in 7-ml increments every 3min at 22 C and ITC
reference power set to 30. Experiments for Supplementary Fig. 5c were conducted
with the same cell and syringe concentrations but UBN1 was injected in 10-ml
increments every 3min at 22 C and ITC reference power was set to 20. Data were
analysed using Origin version 7.0 and corrected for heat of mixing and dilution.
Fluorescence polarization histone-binding assay. Quantitative analysis of the
UBN1/histone interaction was conducted with a FP-based competition-binding
assay; all data were collected using a PerkinElmer EnVision Xcite Multilabel plate
reader. All proteins and peptides for this assay were prepared in a buffer containing
20mM HEPES pH 7.5, 750mM NaCl and 1mM TCEP. We commissioned
commercial synthesis of a UBN1(127–148) peptide with an N-terminal FITC
moiety (Genscript). The Kd of FITC-UBN1(127–148) for binding to H3.3/H4
(Kd¼ 4.3±0.2 mM) and H3.1/H4 (Kd¼ 17.7±2.3 mM) was measured by mon-
itoring the change in fluorescence polarization when increasing H3/H4 is titrated
into a constant concentration of FITC-UBN1(127–148) (10 nM) (Supplementary
Fig. 3a). The curves were fit using a one site—total binding model with
GraphPad Prism (version 5.0a) (Y¼BmaxX/(KdþX)þNSXþ background)s.
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We found that the FITC moiety or linker used to attach it to UBN1 artificially
enhances the UBN1/histone interaction in comparison with both UBN1(92–175)
and UBN1(122–148) (Figs 1c, 2c,d and 3c; Supplementary Figs 3a and 5b). Despite
this, we were still able to use FITC-UBN1(127–148) for a competition-binding
assay. To obtain a suitable fluorescence polarization range in the competition-
binding assay, the concentration of H3/H4 was held at or slightly above the relative
dissociation constant for FITC-UBN1(127–148). Increasing concentration of
UBN1 competitor was titrated into solutions containing constant concentrations of
FITC-UBN1(127–148) (10 nM) and either H3.3/H4 (6.5 mM) or H3.1/H4 (25 mM)
to estimate half-maximal inhibitory concentration values by competition binding.
UBN1 WT and all 27 point mutants were also titrated into a solution containing
only the FITC-UBN1(127–148) to generate curves used to subtract background
polarization, which is possibly caused by UBN1 self-association. Curves for D136A,
S137A, F138A, I139A and D140A had a slightly different scale in comparison with
others and were normalized to the average baseline; normalization did not alter
data interpretation. Competition-binding curves were fit using the one site—total
binding model with GraphPad Prism (version 5.0a). Recombinant H3/H4 are
known to form a strong (H3/H4)2 homotetramer at concentrations above 1 mM45.
Due to this H3/H4 conformation, two molecules of UBN1 are necessary to
completely compete both FITC-UBN1 molecules away from the histone tetramer.
Taking the binding stoichiometry of (UBN1)2/(H3/H4)2 into account, the
concentration of UBN1 reported in the fluorescence polarization titration curves
actually represents half of the molecular concentration of UBN1.
Crystallization and structure determination. We obtained as a generous gift
from Mair Churchill (University of Colorado School of Medicine) the GST-Asf1/
H3.1/H4 polycistronic E. coli co-expression construct that was previously used to
produce Asf1/H3.1/H4 for crystallization and structure determination19. We used
mutagenesis43 to generate a construct encoding Asf1/H3.3/H4 for our purposes.
The GST-Asf1/H3/H4 complex was expressed in BL21-Gold(DE3) cells (Agilent)
induced with 0.8mM IPTG, protein was expressed for 8 h at 28 C. Cell pellets were
resuspended in 50ml of lysis buffer (20mM Tris pH 8.0, 500mM NaCl, 1mM
PMSF and 5mM BME) per litre of cells and lysed with sonication. Lysate was
clarified by centrifugation and the supernatant was incubated with glutathione
agarose resin (Gold Biotechnology) for 1 h before washing the resin with 60
column volumes of wash buffer (20mM Tris pH 8.0, 500mM NaCl and 5mM
BME). The Asf1/H3/H4 complex was then released from the resin with on-column
cleavage using prescission protease. The cleaved Asf1/H3/H4 complex was eluted
with six column volumes of elution buffer (20mM Tris pH 8.0, 500mM NaCl and
1mM TCEP). The free Asf1/H3/H4 complex was then concentrated using a 3K
cutoff centrifugal filter device (Millipore) before a final gel filtration purification
step with a HiLoad 16/600 Superdex S75 pg column (GE Healthcare). The
UBN1(122–148)/Asf1/H3.3/H4 complex was formed by incubating 0.2mM
Asf1/H3.3/H4 with 0.8mM UBN1(122–148) in a buffer containing 20mM Tris pH
8.0, 500mM NaCl and 1mM TCEP before crystallization. Hanging drops for
vapour diffusion were formed by mixing two volumes of protein solution with
one volume of crystallization solution (0.1M Sodium Cacodylate pH 6.0, 8%
polyethylene glycol 8 K and 0.2M NaCl) and crystals appeared within 48 h. X-ray
diffraction data were collected using an in-house Rigaku MicroMax-007HF
microfocus rotating anode X-ray generator and a Saturn 944þ charge-coupled
device detector. The diffraction data were indexed and scaled using HLK3000, and
a Molecular Replacement solution was obtained using Phaser in the Phenix
software suite with Asf1/H3.1/H4 (PDB ID, 2HUE) used as a search model. The
solution was refined using phenix.refine in the Phenix software suite and model
building was carried out using the molecular graphics program Coot. The solution
model contains UBN1(122–142), H3.3(61–134), H4(24–102) and Asf1(1–154).
Electron density was not observed for Asf1 residues 155–169, H3.3 residue 60 and
H4 residues 19–23. Table 1 shows a summary of the refinement statistics.
Simulated annealing Fo Fc omit map for the UBN1 peptide was generated using
phenix.refine in the Phenix software suite. Figures for publication were generated
using the program PyMOL. Structure comparison of UBN1 and DAXX were
carried out using the published crystal structures of DAXX/H3.3/H4 (PDB ID,
4H9N) and DAXX/H3.3(G90M)/H4 (PDB ID, 4H9O)30.
Assembly of Asf1/H3(FL)/H4(FL) complexes. As described previously46,
expression and purification of the heterotrimeric Asf1(1–169)/H3(60–135)/H4
(20–102) complex from E. coli yields a large excess of Asf1 not in complex with
H3/H4 that can be separated from the Asf1/H3/H4 complex on a HiLoad 16/600
Superdex S75 pg column (GE Healthcare). We collected this excess Asf1 to be used
for complex formation with either FL H3.3/H4 or FL H3.1/H4. Complexes were
formed through mixing a twofold excess of Asf1 with H3.3/H4 or H3.1/H4 in a
buffer containing 20mM HEPES pH 7.5, 2.0M NaCl and 1mM TCEP, this
mixture was then dialyzed overnight into a buffer containing 20mM HEPES pH
7.5, 750mM NaCl and 1mM TCEP. The mixture was then injected onto a HiLoad
16/600 Superdex S75 pg column (GE Healthcare) to separate the Asf1/H3/H4
complex from the excess Asf1. The resulting Asf1/H3/H4 was used for ITC
studies.
pFastBacDual HIRA/UBN1. A C-terminally FLAG-tagged open reading frame of
full-length human HIRA encoded by nucleotides 221–3,271 of NM_003325 were
PCR amplified and subcloned into the XmaI and SphI restriction sites 30 to the P10
promoter in pFastBacDual. Nucleotides 843–4,247 of NM_016936 encoding
full-length human UBN1 were PCR amplified and subcloned into the SalI and XbaI
restriction sites 30 to the PH promoter in pFastBacDual. The FID(138–140)AAA
mutation was introduced into UBN1 in the pFastBacDual vector by the Stratagene
QuikChange protocol43.
Expression of recombinant proteins in insect cells. Sequence-confirmed
pFastBac transfer vectors containing sequences for human HIRA, UBN1 and
CABIN1 were transformed into DH10Bac cells. Proper recombination of the
HIRA, UBN1 and CABIN1 sequences into the baculovirus genome was determined
by PCR and positive bacmid DNAs were transfected into Sf9 cells47. High-titer
passage 1 (P1) virus stocks were recovered 120 h post-transfection. A high-titer P2
virus stock was generated by infecting Sf9 at an multiplicity of infection of B0.1,
followed by incubation for 120 h. For productions, 1 106 Sf9 cells per ml in
Sf900-III medium (Invitrogen) were infected with virus at an multiplicity of
infection of 1. Infected cells were harvested 48 h post-infection.
Histone pull-downs with the intact HIRA/UBN1/CABIN1 complex. The
HIRA-FLAG/UBN1 and HIRA-FLAG/UBN1/His-CABIN1 complexes containing
WT UBN1 or UBN1(FID138-140AAA) mutant was purified by suspending
isolated cell pellets in 50ml lysis buffer (20mM Tris pH 8.0, 500mM NaCl, 1mM
PMSF, 1mM BME and a complete EDTA-free protease inhibitor tablet (Roche))
per litre of cells, and lyses with sonication. Lysate was clarified by centrifugation
and the supernatant was incubated with ANTI-FLAG M2 affinity gel
(Sigma-Aldrich) for 2 h before washing the gel with 60 column volumes of wash
buffer (20mM Tris pH 8.0, 500mM NaCl and 1mM BME). The FLAG gel was
bound to capacity for both the WT and mutant complexes. To conduct the FLAG
pull-down assay, 50 ml of bound gel was incubated for 30min with 4 mM H3/H4 in
a buffer with 20mM Tris pH 8.0, 750mM NaCl and 1mM BME. Then the gel was
washed with 120 column volumes of buffer (20mM Tris pH 8.0, 750mM NaCl and
1mM BME) before elution of bound proteins by boiling the gel in SDS gel-loading
buffer. Results of the pull-down assays were analysed through visualization of input
Table 1 | X-ray data collection and refinement statistics.
Data collection*
Space group P3221
Cell dimensions
a, b, c (Å) 90.024, 90.024, 120.734
a, b, g () 90.00, 90.00, 120.00
Wavelength (Å) 1.5418
Resolution (Å) 25.41–2.25 (2.33–2.25)w
Rsym 5.4 (44.0)
I/sI 26.4 (2.7)
Completeness (%) 99.1 (93.3)
Redundancy 6.0 (3.8)
Refinement statistics
Resolution (Å) 25.41–2.25 (2.33–2.25)
No. reflections (total/unique) 725,259/26,431
Rwork/Rfree (%) 20.82/23.48
No. of atoms 2866
Protein 2692
Ligand/ion 16
Water 158
B-factors (Å2)
Protein (Asf1/H3.3/H4) 54.7
Protein (UBN1) 67.2
Ligand/ion 58.6
Water 53.4
R.m.s.d
Bong lengths (Å) 0.003
Bond angles () 0.637
Ramachandran statistics
Favoured (%) 99.1
Allowed (%) 0.90
r.m.s.d, root mean squared deviation
*One crystal was used for data collection and refinement.
wValues in parentheses are for the highest resolution shell.
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and pull-down samples with SDS–polyacrylamide gel electrophoresis. Gels were
stained using Coomassie Brilliant Blue G-250.
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